Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,075Revenue $M45.9Net Margin (%)-57.6Z-Score16.4
Enterprise Value $M896EPS $-0.4Operating Margin %-58.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-57.6Higher ROA y-yY
Price/Book5.210-y EBITDA Growth Rate %-2.7Quick Ratio9.1Cash flow > EarningsY
Price/Sales22.95-y EBITDA Growth Rate %-4.7Current Ratio9.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-11.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-13.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.2ROI % (ttm)-33.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJean-Marie Eveillard 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 15.548%Add 34.10%536,380
SGMOJean-Marie Eveillard 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 15.54-23%Reduce -52.81%400,000
SGMOJean-Marie Eveillard 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 15.5436%Add 99.73%847,550
SGMOJean-Marie Eveillard 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 15.5443%New holding300,000
SGMOJean-Marie Eveillard 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 15.5459%Sold Out0
SGMOJean-Marie Eveillard 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 15.5473%New holding260,600
SGMOJean-Marie Eveillard 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 15.5474%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wolff Henry WardExec VP & CFO 2015-03-19Sell10,000$18-17.17view
LANPHIER EDWARD O IIPresident & CEO 2015-03-16Sell25,000$17.29-13.77view
Wolff Henry WardExec VP & CFO 2015-03-10Sell12,000$16.68-10.61view
Mento Steven JDirector 2015-03-05Sell6,501$18.3-18.52view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-03-05Sell15,000$18.29-18.48view
Wolff Henry WardExec VP & CFO 2015-03-04Sell10,000$18-17.17view
RINGO WILLIAM RDirector 2015-03-03Sell2,200$17.21-13.36view
Gregory Philip DSVP of Research & CSO 2015-03-02Sell15,000$17.26-13.62view
LANPHIER EDWARD O IIPresident & CEO 2015-02-17Sell25,000$15.69-4.97view
Ramasastry SairaDirector 2015-02-12Sell10,000$15-0.6view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 06 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

    More From Other Websites
    Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New... Mar 19 2015
    Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New... Mar 18 2015
    Scientists call for halt on experiments changing DNA of human embryos Mar 12 2015
    Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative... Mar 09 2015
    Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative... Mar 09 2015
    Study of potential HIV 'cure' wins FDA nod Mar 03 2015
    Sangamo Biosciences (SGMO) is in Overbought Territory: What's Next? - Tale of the Tape Mar 03 2015
    Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed... Feb 26 2015
    Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed... Feb 26 2015
    Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care... Feb 25 2015
    SANGAMO BIOSCIENCES INC Files SEC form 10-K, Annual Report Feb 25 2015
    Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care... Feb 25 2015
    Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo... Feb 12 2015
    Sangamo reports 4Q loss Feb 10 2015
    Sangamo reports 4Q loss Feb 10 2015
    Sangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today Feb 10 2015
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 10 2015
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results Feb 10 2015
    Q4 2014 Sangamo BioSciences Inc Earnings Release - After Market Close Feb 10 2015
    Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog Feb 09 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK